We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Asks FDA to Let Industry Self-Regulate Trial Transparency
PhRMA Asks FDA to Let Industry Self-Regulate Trial Transparency
October 4, 2013
The drug industry itself is in the best position to decide how to make preclinical and clinical trial data more widely available, according to PhRMA.